The rapid regenerative response ofthe rat liver to partial hepatectomy is associated with a decline in liver epidermal growth factor receptor numbers which implies that ligand epidermal growth factor receptor interactions maybe important in initiating and/or modulating this process. The The liver has a remarkable capacity to regenerate after viral and toxic hepatitis, and surgical resection.' Hepatocyte proliferation takes place by division of existing adult hepatocytes, but the factors initiating this proliferation are complex and incompletely understood.2 A significant early event in hepatic regeneration, studied in rats after 70% partial hepatectomy, is down regulation of the epidermal growth factor receptor.3-7 In vitro studies have clearly shown that the addition of the epidermal growth factor to hepatocyte membranes and hepatocytes causes epidermal growth factor receptor phosphorylation and down regulation, events which lead to stimulation of hepatocyte DNA synthesis implying that the epidermal growth factor receptor is involved in initiation of hepatic regeneration in vivo.5`8 TGF-a, a small polypeptide with a marked structural homology to epidermal growth factor also interacts with the epidermal growth factor receptor and can stimulate DNA synthesis in hepatocytes in culture.9'-" Unlike the epidermal growth factor, generation of TGF-ct has been shown within the liver after partial hepatectomy, and therefore maybe the true mediator of the observed changes in the epidermal growth factor receptor.4 12
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In animals killed 48 hours after receiving 800 mg/kg galactosamine, the level of incorporation of 3H-thymidine into liver was 25-fold greater than in control animals. This increase had commenced by 24 hours, with levels of incorporation at this time being twice that in controls (Table I) .
There was no difference in liver DNA 3H-thymidine incorporation at 48 hours between sham operated animals and those receiving saline.
LIVER DAMAGE
The histological appearance of tissue taken 48 hours after administration of galactosamine at a dose of 350 mg/kg showed the presence of diffusely scattered swollen and vacuolated hepatocytes. There was little lymphocytic cell infiltration. Incorporation of 3H-thymidine was predominantly into the nuclei of hepatocytes (Fig la) . At a dose of 800 mg/kg body weight patchy necrotic areas were wide spread (Fig 1 b) .
Glutamic oxaloacetic transaminase (GOT/ AST: EC2.6.1.1) concentrations were substan- tially raised in galactosamine treated animals above rats receiving saline. At 48 hours after injection, serum concentrations of control animals were 81 (50-100) Sigma units/ml (mean and range for three animals), 182 (120-340) Sigma units/ml for animals receiving 350 mg/kg galactosamine, and 1570 (950-2160) Sigma units/ml for animals receiving 800 mg/kg galactosamine.
EPIDERMAL GROWTH FACTOR BINDING
Twenty four hours after partial hepatectomy, there was a 50% reduction in epidermal growth factor binding to liver plasma membranes with little change in epidermal growth factor receptor affinity, confirming previous observations.36 Epidermal growth factor binding to plasma membranes from livers of rats receiving 350 mg/ kg galactosamine was reduced by 35-60% 48 hours after administration of the chemical, whereas the higher dose, of 800 mg/kg, reduced epidermal growth factor binding by >90% (Fig 2 and Table II) . Galactosamine had no effect on the epidermal growth factor binding capacity of normal liver plasma membranes when included in the binding assay medium at 5 (Table III) .
VIABILITY AND EPIDERMAL GROWTH FACTOR BINDING
Galactosamine at a dose of 1 mM was directly toxic to primary hepatocyte cultures such that at 20 hours and 47 hours viability, as assessed by trypan blue exclusion was 70% and less than 20% respectively. In the presence of uridine (0 5 mM) cell viability remained at control levels. There was a 56% reduction in 125I epidermal growth factor binding after 47 hours of culture in galactosamine (Table IV) . Uridine prevented the fall in epidermal growth factor binding.
Discussion
In this experimental study we have shown that The experiments reported here therefore support the concept that regeneration after chemical damage to the liver involves similar mechanisms to those after partial hepatectomyat least with regard to the modulation of the epidermal growth factor receptor. The timing of the major change in epidermal growth factor binding, later than that occurring after partial hepatectomy, is compatible with the concept that it is loss of hepatic mass after administration of the chemical that is the stimulus to regeneration. It is of interest that similar changes in intrahepatic expression of the recently characterised hepatic growth factor occur in both toxic (CC14) and surgical induced damage of the rat liver, but again the changes in hepatic growth factor expression are earlier after hepatic resection than after chemical damage. 27 Such findings suggest that observations on the control of hepatocyte proliferation derived from the partial resection model may be extrapolated to the more complex problems of repair after chemical or viral hepatitis which are more relevant to disease in man.
